Teva's new asthma inhaler poses first competition for GSK's Advair

(Reuters) - Teva Pharmaceutical Industries Ltd on Thursday launched an asthma inhaler that will be the first direct competition to GlaxoSmithKline's best-selling Advair.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Advair | Asthma | Health